Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
ResMed Inc. stock rises Monday, outperforms market
Shares of ResMed Inc. RMD inched 0.51% higher to $246.18 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.28% to 5,718.57 and the Dow Jones Industrial Average DJIA rising 0.15% to 42,124.65.
Why ResMed Stock Tumbled by 5% Today
Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost more than 5% of their value on news of an analyst's downgrade and his new, bearish outlook.
Stock of the day: ResMed
ResMed faces a 3% drop in share price after concerns over Eli Lilly’s Ozempic, which could impact the demand for CPAP machines in the sleep apnea market.
ResMed Inc. stock rises Friday, outperforms market
Shares of ResMed Inc. RMD inched 0.81% higher to $244.94 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.09% to 42,
Why is the ResMed share price taking a thumping on Thursday?
Investors seem to be signalling out ResMed for punishment. The post Why is the ResMed share price taking a thumping on Thursday? appeared first on The Motley Fool Australia.
5d
on MSN
ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.
Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.
5d
Why ResMed's Rally Is Just Getting Started
ResMed's AirSense 11 platform and myAir app enhance patient engagement and efficiency. Check out why I remain bullish on RMD ...
bovnews
4d
Resmed Inc (RMD) Stock Settles at $238.03: What’s Contributing to This Price Point?
Wolfe Research has recently reduced Resmed Inc (RMD) stock to Underperform rating, as announced on September 18, 2024, according to Finviz. Earlier, on September 4, 2024, Needham had reduced the stock ...
5d
on MSN
Top Stock Movers Now: US Steel, VF Corp., ResMed, and More
Major U.S. indexes were little changed at midday Wednesday, ahead of the Federal Reserve's decision on interest rates.
5d
ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of Safety
ResMed achieved double-digit revenue growth through acquisitions and operating efficiencies, with improving capital ...
6d
ResMed Faces Market Disruption and Limited Growth: A Sell Rating Analysis
Wolfe Research analyst Michael Polark downgraded the rating on Resmed (RMD – Research Report) to a Sell yesterday, setting a price target ...
5d
ResMed投资者日前景稳定,分析师持谨慎态度
Needham在周三维持对ResMed (NYSE:RMD)的持有评级,该公司是一家以生产睡眠相关产品闻名的医疗设备公司。这一立场是在ResMed定于2024年9月30日在纽约市举行投资者日之前做出的。这是自2021年9月以来公司首次举办此类活动,凸显了过去三年公司发生的重大变化。 ResMed在疫情后供应链已恢复正常,并成功从其未评级的竞争对手Philip Respironics那里获得了相当大 ...
1d
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 74%
To get a sense of who is truly in control of ResMed Inc. ( NYSE:RMD ), it is important to understand the ownership structure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
New York Stock Exchange
S&P 500 Index
Super Micro
Intuitive Machines
General Mills
Feedback